Mr. Garen Sarafian reports

BAUSCH HEALTH TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2025 RESULTS ON FEBRUARY 18, 2026

Bausch Health Companies Inc. will release fourth quarter and full-year 2025 financial results after market close on Wednesday, Feb. 18, 2026. Bausch Health will host a live conference call and webcast at 5 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Bausch Health website prior to the start of the call.

Conference call details

Date:  Wednesday, Feb. 18, 2026

Time:  5 p.m. U.S. EST

Webcast:  at the company's website

A replay of the conference call will be available on the investor relations website.

About Bausch Health Companies Inc.

Bausch Health is a global diversified pharmaceutical company enriching lives through its relentless drive to deliver better health care outcomes. It develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health through its controlling interest in Bausch + Lomb. Its ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors.